14.28
Precedente Chiudi:
$14.57
Aprire:
$14.56
Volume 24 ore:
898.72K
Relative Volume:
0.52
Capitalizzazione di mercato:
$1.50B
Reddito:
-
Utile/perdita netta:
$-115.88M
Rapporto P/E:
-9.232
EPS:
-1.5468
Flusso di cassa netto:
$-104.72M
1 W Prestazione:
+0.49%
1M Prestazione:
-7.63%
6M Prestazione:
-56.73%
1 anno Prestazione:
-18.40%
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Confronta EWTX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
EWTX
Edgewise Therapeutics Inc
|
14.28 | 1.49B | 0 | -115.88M | -104.72M | -1.5468 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-04-30 | Iniziato | Guggenheim | Buy |
2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
2025-01-22 | Iniziato | Stifel | Hold |
2024-11-22 | Iniziato | Evercore ISI | Outperform |
2024-03-07 | Iniziato | Piper Sandler | Overweight |
2023-05-01 | Iniziato | Truist | Buy |
2022-08-25 | Downgrade | Goldman | Neutral → Sell |
2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Two Sigma Investments LP Sells 129,791 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Edgewise Therapeutics: Upcoming DMD Trial Data May Disappoint (NASDAQ:EWTX) - Seeking Alpha
Nuveen Asset Management LLC Raises Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Nuveen Asset Management LLC Acquires 158,452 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Woodline Partners LP Has $15.15 Million Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
BNP Paribas Financial Markets Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
106,562 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Purchased by Point72 Asset Management L.P. - MarketBeat
Frazier Life Sciences Management L.P. Cuts Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges By Investing.com - Investing.com South Africa
Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges - Investing.com Nigeria
Soleus Capital Management L.P. Acquires New Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Polar Asset Management Partners Inc. Trims Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Tang Capital Management LLC Takes Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Deutsche Bank AG Grows Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
How to Take Advantage of moves in (EWTX) - news.stocktradersdaily.com
Northern Trust Corp Acquires 35,426 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Brokerages Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) PT at $40.22 - MarketBeat
Balyasny Asset Management L.P. Buys Shares of 23,364 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
All You Need to Know About Edgewise Therapeutics (EWTX) Rating Upgrade to Buy - MSN
Ensign Peak Advisors Inc Acquires New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2025 - PR Newswire
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is MPM Bioimpact LLC's 3rd Largest Position - MarketBeat
Paradigm Biocapital Advisors LP Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Parkman Healthcare Partners LLC Sells 275,897 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Janus Henderson Group PLC Purchases 425,421 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
D. E. Shaw & Co. Inc. Purchases 231,023 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
J. Goldman & Co LP Increases Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Research Analysts Offer Predictions for EWTX FY2029 Earnings - MarketBeat
Granahan Investment Management LLC Sells 211,892 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Northern Trust Corp Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Cubist Systematic Strategies LLC Makes New $5.86 Million Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - Yahoo Finance
Muscle Disease Leader Edgewise Therapeutics Takes Stage at RBC Healthcare Conference - Stock Titan
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by DAFNA Capital Management LLC - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Algert Global LLC - MarketBeat
Deerfield Management Company L.P. Series C Buys 297,503 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):